VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+23.55%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$135M
AUM Growth
+$62.1M
(+86%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
38.14%
Top 10 Holdings %
Top 10 Hldgs %
44.79%
Holding
161
New
7
Increased
113
Reduced
25
Closed
15
Top Buys
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
$5.09M |
| 2 |
EEP
Enbridge Energy Partners
EEP
|
$3.39M |
| 3 |
WPZ
Williams Partners L.P.
WPZ
|
$3.33M |
| 4 |
Plains All American Pipeline
PAA
|
$3.25M |
| 5 |
OKS
Oneok Partners LP
OKS
|
$2.89M |
Top Sells
| 1 |
Targa Resources
TRGP
|
$615K |
| 2 |
XNPT
XENOPORT, INC.
XNPT
|
$458K |
| 3 |
Exelixis
EXEL
|
$314K |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$310K |
| 5 |
Theravance Biopharma
TBPH
|
$304K |
Sector Composition
| 1 | Energy | 64.18% |
| 2 | Healthcare | 25.09% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
126
Adaptimmune Therapeutics
ADAP
$10.9M
| $220K | 0.16% |
26,974
-1,208
| -4% | -$9.85K |
|
|
CEMP
127
DELISTED
Cempra, Inc.
CEMP
| $219K | 0.16% |
13,284
+5,226
| +65% | +$86.2K |
|
|
IMGN
128
DELISTED
Immunogen Inc
IMGN
| $218K | 0.16% |
70,796
+51,539
| +268% | +$159K |
|
129
TG Therapeutics
TGTX
$5.11B
| $214K | 0.16% |
35,297
+11,311
| +47% | +$68.6K |
|
|
ALDR
130
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $214K | 0.16% |
8,582
+1,309
| +18% | +$32.6K |
|
131
Agios Pharmaceuticals
AGIO
$2.09B
| $212K | 0.16% |
5,068
+114
| +2% | +$4.77K |
|
|
AIMT
132
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $211K | 0.16% |
19,501
+5,835
| +43% | +$63.1K |
|
|
ACHN
133
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $210K | 0.16% |
26,915
+1,204
| +5% | +$9.39K |
|
134
Karyopharm Therapeutics
KPTI
$57.2M
| $205K | 0.15% |
2,041
+846
| +71% | +$85K |
|
135
Ultragenyx Pharmaceutical
RARE
$3.07B
| $198K | 0.15% |
4,050
+1,646
| +68% | +$80.5K |
|
136
uniQure
QURE
$985M
| $195K | 0.14% |
26,511
+12,329
| +87% | +$90.7K |
|
|
GBT
137
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $194K | 0.14% |
11,710
+4,128
| +54% | +$68.4K |
|
138
Prothena Corp
PRTA
$460M
| $193K | 0.14% |
5,509
+1,859
| +51% | +$65.1K |
|
|
IMMU
139
DELISTED
Immunomedics Inc
IMMU
| $188K | 0.14% |
81,010
-6,052
| -7% | -$14K |
|
140
Esperion Therapeutics
ESPR
$540M
| $154K | 0.11% |
15,540
+4,529
| +41% | +$44.9K |
|
|
NS
141
DELISTED
NuStar Energy L.P.
NS
| $152K | 0.11% |
3,057
+1,469
| +93% | +$73K |
|
|
RGLS
142
DELISTED
Regulus Therapeutics
RGLS
| $134K | 0.1% |
386
+132
| +52% | +$45.8K |
|
|
SEP
143
DELISTED
Spectra Engy Parters Lp
SEP
| $132K | 0.1% |
2,788
+1,339
| +92% | +$63.4K |
|
144
Oneok
OKE
$45.7B
| $113K | 0.08% |
+2,378
| New | +$113K |
|
145
United States Oil Fund
USO
$939M
| $16K | 0.01% |
178
-2,322
| -93% | -$209K |
|
146
Arbutus Biopharma
ABUS
$805M
| – | – |
-54,471
| Closed | -$225K |
|
147
Ardelyx
ARDX
$1.57B
| – | – |
-12,922
| Closed | -$100K |
|
148
State Street
STT
$32B
| – | – |
0
| – | – |
|
|
TVRD
149
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| – | – |
-452
| Closed | -$101K |
|
|
CMRX
150
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-7,232
| Closed | -$37K |
|